• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IIa型多发性内分泌腺瘤病中的原发性甲状旁腺功能亢进症:法国多中心回顾性研究。降钙素肿瘤研究组(GETC,法国降钙素肿瘤研究组),法国内分泌外科医生协会。

Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.

作者信息

Kraimps J L, Denizot A, Carnaille B, Henry J F, Proye C, Bacourt F, Sarfati E, Dupond J L, Maes B, Travagli J P, Boneu A, Roger P, Houdent C, Barbier J, Modigliani E

机构信息

GETC, Department of Endocrinology, Avicenne Hospital, 125 Route de Stalingrad, 93009 Bobigny, France.

出版信息

World J Surg. 1996 Sep;20(7):808-12; discussion 812-3. doi: 10.1007/s002689900123.

DOI:10.1007/s002689900123
PMID:8678955
Abstract

Primary hyperparathyroidism (PHPT) in multiple endocrine neoplasia (MEN) type IIa is rare, occurring in 20% to 30% of the patients. The aim of this study was to evaluate clinical findings, surgical therapy, and outcome for 56 patients affected by PHPT among 249 MEN-IIa patients collected from 84 families assembled by the Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group). This retrospective study was based on cases registered by the GETC (20 participating centers) from 1969 to 1994. Characteristics of PHPT in 56 patients (31 women, 25 men) with MEN-IIa were reviewed. All but two underwent cervicotomy. The median age at diagnosis was 37.6 years. PHPT was found concomitantly with medullary thyroid carcinoma (MTC) or pheochromocytoma in 43 patients (77%). PHPT was asymptomatic in 68% of the patients. Serum calcium levels ranged from 2.20 to 3.70 mmol/L (median 2.82 mmol/L; normal 2. 10-2.60 mmol/L). The number of parathyroid glands removed at surgery was 0 (n = 2), 1 (n = 24), 2 (n = 5), > 2 (n = 12), 4 (n = 11). Pathology (initial surgery) consisted of 24 adenomas, 4 double adenomas, and 25 hyperplasia. Cure after initial surgery was obtained in 89%, including a 22% incidence of hypoparathyroidism. There were 6 cases (11%) with persistent PHPT. With a mean follow-up of 6.4 years, five patients (9%) had recurrent PHPT. The results indicate that MEN-IIa-related PHPT is generally associated with mild, often asymptomatic hypercalcemia. Despite recurrences encountered 5 to 15 years after the first cervicotomy, resection of only macroscopically enlarged glands generally appears sufficient. Subtotal or total parathyroidectomy with autotransplantation is associated with a high rate of hypoparathyroidism.

摘要

多发性内分泌腺瘤病(MEN)IIa型中的原发性甲状旁腺功能亢进症(PHPT)较为罕见,在20%至30%的患者中出现。本研究的目的是评估从法国降钙素肿瘤研究组(GETC)召集的84个家族收集的249例MEN-IIa患者中56例受PHPT影响患者的临床发现、手术治疗及预后情况。这项回顾性研究基于GETC(20个参与中心)1969年至1994年登记的病例。对56例(31例女性,25例男性)MEN-IIa型PHPT患者的特征进行了回顾。除2例患者外,其余均接受了颈部手术。诊断时的中位年龄为37.6岁。43例(77%)患者的PHPT与甲状腺髓样癌(MTC)或嗜铬细胞瘤同时发现。68%的患者PHPT无症状。血清钙水平范围为2.20至3.70 mmol/L(中位值2.82 mmol/L;正常范围2.10 - 2.60 mmol/L)。手术切除甲状旁腺的数量为0个(n = 2)、1个(n = 24)、2个(n = 5)、>2个(n = 12)、4个(n = 11)。病理检查(初次手术)包括24例腺瘤、4例双腺瘤和25例增生。初次手术后89%的患者治愈,其中甲状旁腺功能减退症的发生率为22%。有6例(11%)患者持续性PHPT。平均随访6.4年,5例(9%)患者复发性PHPT。结果表明,MEN-IIa相关的PHPT通常与轻度、常无症状的高钙血症相关。尽管在首次颈部手术后5至15年出现复发,但仅切除肉眼可见增大的腺体通常似乎就足够了。次全或全甲状旁腺切除术加自体移植与甲状旁腺功能减退症的高发生率相关。

相似文献

1
Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.IIa型多发性内分泌腺瘤病中的原发性甲状旁腺功能亢进症:法国多中心回顾性研究。降钙素肿瘤研究组(GETC,法国降钙素肿瘤研究组),法国内分泌外科医生协会。
World J Surg. 1996 Sep;20(7):808-12; discussion 812-3. doi: 10.1007/s002689900123.
2
Primary hyperparathyroidism in multiple endocrine neoplasia type 2A.2A 型多发性内分泌腺瘤病中的原发性甲状旁腺功能亢进症
J Intern Med. 1995 Oct;238(4):369-73. doi: 10.1111/j.1365-2796.1995.tb01212.x.
3
Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group.I型多发性内分泌腺瘤病中的甲状旁腺功能亢进症:来自多内分泌肿瘤研究组256例患者系列研究的手术趋势及结果
World J Surg. 2001 Jul;25(7):886-90. doi: 10.1007/s00268-001-0046-z.
4
Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated?基因诊断后IIa型多发性内分泌腺瘤病的预防性手术:甲状旁腺移植是否适用?
World J Surg. 1996 Sep;20(7):814-20; discussion 820-1. doi: 10.1007/s002689900124.
5
Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.2A 型多发性内分泌腺瘤病患者甲状旁腺功能亢进的外科治疗
Surgery. 1996 Dec;120(6):966-73; discussion 973-4. doi: 10.1016/s0039-6060(96)80042-0.
6
Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?与I型和IIa型多发性内分泌肿瘤相关的原发性甲状旁腺功能亢进症手术治疗后的长期生化结果:是否需要或多或少地扩大手术范围?
Eur J Surg. 2001 Mar;167(3):173-8. doi: 10.1080/110241501750099294.
7
Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.2A和2B型多发性内分泌腺瘤病患儿的甲状腺髓样癌
J Pediatr Surg. 1996 Jan;31(1):177-81; discussion 181-2. doi: 10.1016/s0022-3468(96)90343-7.
8
MEN type 2a presenting as an intra-abdominal emergency.表现为腹腔内急症的2a型多发性内分泌腺瘤病
Aust N Z J Surg. 1997 Nov;67(11):824-6. doi: 10.1111/j.1445-2197.1997.tb04599.x.
9
Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy.家族性多发性内分泌腺瘤病1型中的原发性甲状旁腺功能亢进症。甲状旁腺切除术后血清钙水平的长期随访。
Am J Med. 1985 Mar;78(3):467-74. doi: 10.1016/0002-9343(85)90340-7.
10
[Causes of death in patients with medullary cancer of the thyroid. GETC. Groupe d'Etude des Tumeurs à Calcitonine].[甲状腺髓样癌患者的死因。GETC。降钙素瘤研究组]
Presse Med. 1996 Nov 30;25(37):1819-22.

引用本文的文献

1
MEN2: surgical precision in the era of precision medicine.MEN2:精准医学时代的手术精准性。
Endocr Relat Cancer. 2025 Jun 6;32(6). doi: 10.1530/ERC-24-0251. Print 2025 Jun 1.
2
Primary Hyperparathyroidism in MEN2 Syndromes.MEN2综合征中的原发性甲状旁腺功能亢进症。
Recent Results Cancer Res. 2025;223:237-246. doi: 10.1007/978-3-031-80396-3_9.
3
Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.遗传性甲状腺髓样癌:基因型与表型的相关性
Recent Results Cancer Res. 2025;223:183-209. doi: 10.1007/978-3-031-80396-3_7.
4
Heritable hyperparathyroidism: Genetic insights and clinical implications.遗传性甲状旁腺功能亢进症:遗传学见解与临床意义。
Best Pract Res Clin Endocrinol Metab. 2025 Mar;39(2):101984. doi: 10.1016/j.beem.2025.101984. Epub 2025 Mar 1.
5
Molecular diagnostic approaches in detecting rearranged during transfection oncogene mutations in multiple endocrine neoplasia type 2.检测2型多发性内分泌肿瘤转染期间重排致癌基因突变的分子诊断方法。
World J Clin Cases. 2024 Nov 6;12(31):6436-6440. doi: 10.12998/wjcc.v12.i31.6436.
6
Familial states of primary hyperparathyroidism: an update.家族性原发性甲状旁腺功能亢进症:最新进展。
J Endocrinol Invest. 2024 Sep;47(9):2157-2176. doi: 10.1007/s40618-024-02366-7. Epub 2024 Apr 18.
7
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?2型多发性内分泌腺瘤病患者的基因型特异性表型是否如现行指南所预测的那样出现?
Cancers (Basel). 2024 Jan 24;16(3):494. doi: 10.3390/cancers16030494.
8
Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue.自体移植组织中的远程复发性原发性甲状旁腺功能亢进症。
Cureus. 2023 Jun 21;15(6):e40715. doi: 10.7759/cureus.40715. eCollection 2023 Jun.
9
Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study.丹麦1930 - 2021年2A型多内分泌腺瘤病中的原发性甲状旁腺功能亢进:一项基于全国人群的回顾性研究
Cancers (Basel). 2023 Apr 2;15(7):2125. doi: 10.3390/cancers15072125.
10
Primary Hyperparathyroidism in Young Adult Patients.青年原发性甲状旁腺功能亢进症。
Ann Surg Oncol. 2023 Jul;30(7):4156-4164. doi: 10.1245/s10434-023-13344-3. Epub 2023 Mar 17.